Σελίδες

Κυριακή 30 Σεπτεμβρίου 2018

U.S.A.s interesting latest


U.S. Food and Drug Administration Header

MedWatch - The FDA Safety Information and Adverse Event Reporting Program

A new MedWatch Safety Alert: Caution When Using Pen Needles to Inject Medicines intended for:Patient, Health Professional, Pharmacy, Endocrinology was just added to the FDA Safety Communications Webpage.
You can read the complete MedWatch Safety Alert that includes recommendations at: https://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm621788.htm

A new MedWatch Safety Alert: Differences in strength expression on product labels of compounders and conventional manufacturers may lead to dosing errors intended for: Pharmacy, Health Professional, Risk Manager was just added to the FDA MedWatch Webpage.
You can read the complete MedWatch Safety Alert that includes recommendations at: https://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/PharmacyCompounding/ucm621769.htm
A new MedWatch Safety Alert recall: Oscor Inc. Issues Recall of TB – Temporary Bipolar Pacing Lead (Unshrouded 2 mm Pins Models) was just added to the FDA Recalls webpage.
You can read the complete recall alert at: https://www.fda.gov/Safety/Recalls/ucm621931.htm
A new MedWatch Safety Alert recall: Ventana Medical Systems Recalls Multiple Detection Kits Due to Potential for False Negative Results Caused by Reagent Dispenser Issues was just added to the FDA Recalls webpage.
A new MedWatch Safety Alert recall: Pro-Med Instruments Recalls the DORO LUCENT Headrest Due to Possible Malfunction and Failure was just added to the FDA Recalls webpage.
A new MedWatch Safety Alert recall: Endo Pharmaceuticals Issues Voluntary Nationwide Recall for Two Lots of Robaxin® 750mg Tablets 100 Count Bottle Packs Due to Incorrect Daily Dosing Information on Label was just added to the FDA Recalls webpage.
You can read the complete recall alert at: https://www.fda.gov/Safety/Recalls/ucm622008.htm


Bureau of Consumer Protection. Business Alerts From the Federal Trade Commission

By Lesley Fair
Four companies just entered into proposed agreements with the FTC to settle charges that they made misrepresentations about their participation in the EU-U.S. Privacy Shield. The cases reflect the FTC’s continuing commitment to enforcing the framework. Two of the complaints also focus on a Privacy Shield obligation that may be worth more of your company’s attention.
Read more >